Immunogenicity of Bivalent Human Papillomavirus DNA Vaccine Using Human Endogenous Retrovirus Envelope-Coated Baculoviral Vectors in Mice and Pigs

Human papillomavirus is known to be the major pathogen of cervical cancer. Here, we report the efficacy of a bivalent human papillomavirus type 16 and 18 DNA vaccine system following repeated dosing in mice and pigs using a recombinant baculovirus bearing human endogenous retrovirus envelope protein...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lee, Hee-Jung, Hur, Yoon-Ki, Cho, Youn-Dong, Kim, Mi-Gyeong, Lee, Hoon-Taek, Oh, Yu-Kyoung, Kim, Young Bong
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2012
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3507738/
https://ncbi.nlm.nih.gov/pubmed/23209698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0050296
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi